D-0261-2024 Class I Ongoing
FDA drug recall D-0261-2024 was initiated by PFIZER on December 21, 2023 and is designated Class I. Reason for recall: Presence of particulate matter: glass The recall status is ongoing. Affected quantity: 3,546 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- January 31, 2024
- Initiation Date
- December 21, 2023
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,546 vials
Product Description
Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18
Reason for Recall
Presence of particulate matter: glass
Distribution Pattern
Nationwide in the USA, Netherlands and Libya
Code Information
Lot #: BL12206A, Exp date 06/30/2024